Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

United Therapeutics Just Sent Liquidia Stock Lower After Patent Battle

Liquidia (LQDA) stock closed meaningfully lower on Thursday after United Therapeutics (UTHR) secured a major victory against the biopharmaceutical firm in a U.S. District Court. The Delaware court ruled that LQDA’s flagship pulmonary hypertension drug Yutrepia infringes on two valid claims of UHTR’s patent number 11,826,327.

Following the recent crash, Liquidia shares are trading about 70% below their recent high.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.